Page History

...

Toggle Cloak

miRNA Detection

Cloak

Experiment #1L7ae Repression

Attempt #1

GOAL: Test the strength of L7ae

3

complete

7/14/14: Seed cells

22

complete

7/15/14: Transfect MAV1212-hEF1a-eBFP2 (1084.0 ng/uL), Mutant hEF1a-2xKturn-eGFP (551.4 ng/uL) and Wild Type hEF1a-2xKturn-eGFP (287.0 ng/uL) into HEK cells

0

complete

7/17/14 (12 pm): Flow Cytometer

DNA Dilution: 5 uL MAV1212-hEF1a-eBFP2, 10 uL Mutant Hef1a-2xKturn-eGFP, 20 uL Wild Type Hef1a-2xKturn-eGFP

24-WELL PLATE TRANSFECTION MAP:

(B)1

MAV1212-hEF1a-eBFP2

(B)₂

MAV1212-hEF1a-eBFP2

//////

(G_M)1

Mutant Hef1a-2xKturn-eGFP

(G_M)₂

Mutant Hef1a-2xKturn-eGFP

(G_M+ B)₁

Mutant Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_M+ B)₂

Mutant Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_M+ B + L)₁

Mutant Hef1a-2xKturn-eGFP
Wild Type Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_M+ B + L)₂

Mutant Hef1a-2xKturn-eGFP
Wild Type Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_WT)1

Wild Type Hef1a-2xKturn-eGFP

(G_WT)₂

Wild Type Hef1a-2xKturn-eGFP

(G_WT+ B)₁

Wild Type Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_WT+ B)₂

Wild Type Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_WT+ B + L)₁

Wild Type Hef1a-2xKturn-eGFP
Mutant Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_WT+ B + L)₂

Wild Type Hef1a-2xKturn-eGFP
Mutant Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

Neg Ctrl

Dummy DNA
With Lipofectamine

Neg Ctrl

Dummy DNA
With Lipofectamine

Neg/Neg Ctrl

No DNA
No Lipofectamin

Neg/Neg Ctrl

No DNA
No Lipofectamine

//////

RESULT: Transfection efficiency ~35%. FACS data is available Inconclusive. No L7ae was added.

Attempt #2

2

complete

7/16/14: Seed cells

1

complete

7/17/14: Transfect MAV1212-hEF1a-eBFP2 (1084.0 ng/uL), Mutant hEF1a-2xKturn-eGFP (551.4 ng/uL) and Wild Type hEF1a-2xKturn-eGFP (287.0 ng/uL), MAV1212-hEF1a-L7ae (1686.4 ng/uL) into HEK cells

7

complete

7/19/14 (10 am): Flow Cytometer

DNA Dilution: 5 uL MAV1212-hEF1a-eBFP2, 10 uL Mutant Hef1a-2xKturn-eGFP, 20 uL Wild Type Hef1a-2xKturn-eGFP, 3 uL MAV1212-hEF1a-L7ae

24-WELL PLATE TRANSFECTION MAP:

(B)1

MAV1212-hEF1a-eBFP2

(B)₂

MAV1212-hEF1a-eBFP2

//////

(G_M)1

Mutant Hef1a-2xKturn-eGFP

(G_M)₂

Mutant Hef1a-2xKturn-eGFP

(G_M+ B)₁

Mutant Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_M+ B)₂

Mutant Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_M+ B + L)₁

Mutant Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2
MAV1212-hEF1a-L7ae

(G_M+ B + L)₂

Mutant Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2
MAV1212-hEFa-L7ae

(G_WT)1

Wild Type Hef1a-2xKturn-eGFP

(G_WT)₂

Wild Type Hef1a-2xKturn-eGFP

(G_WT+ B)₁

Wild Type Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_WT+ B)₂

Wild Type Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2

(G_WT+ B + L)₁

Wild Type Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2
MAV1212-hEFa1-L7ae

(G_WT+ B + L)₂

Wild Type Hef1a-2xKturn-eGFP
MAV1212-hEF1a-eBFP2
MAV1212-hEF1a-L7ae

Neg Ctrl

Dummy DNA
With Lipofectamine

Neg Ctrl

Dummy DNA
With Lipofectamine

Neg/Neg Ctrl

No DNA
No Lipofectamin

Neg/Neg Ctrl

No DNA
No Lipofectamine

//////

RESULT: Transfection efficiency ~35%. FACS data is available : Inconclusive: Too much DNA in each well.

Attempt #3

17

complete

7/24/14: Seed cells

18

complete

7/25/14: Transfect MAV1212-hEF1a-eBFP2, Mutant hEF1a-2xKturn-eGFP, Wild Type hEF1a-2xKturn-eGFP, MAV1212-hEF1a-L7ae, hEF1a-PirB (dummy DNA) all at ~500 ng/uL into HEK cells

19

complete

7/27/14 (10 am): Flow Cytometry

DNA Dilution: MAV1212-hEF1a-eBFP2 (0.47 uL), Wild Type CAG-2xKturn-eGFP (0.96 uL), Mutant CAG-2xKturn-eGFP (0.96 uL), MAV1212-hEF1a-L7ae (0.71 uL), hEF1a-PirB (to 1 ug)

24-WELL PLATE TRANSFECTION MAP:

1. (B)₁

MAV1212-hEF1a-eBFP2 (1.0 fmole)

hEF1a-PirB (1.5 fmole = 1.60 uL)

2. (B)₂

MAV1212-hEF1a-eBFP2 (1.0 fmole)

hEF1a-PirB (1.5 fmole = 1.60 uL)

//////

3. (G_WT+ B)₁

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-2xKturn-eGFP (1.5 fmoles)

hEF1a-PirB (1.0 fmole = 0.99 uL)

4. (G_WT+ B)2

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-2xKturn-eGFP (1.5 fmoles)

hEF1a-PirB (1.0 fmole = 0.99 uL)

5. (G_WT+ B + L)₁

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-2xKturn-eGFP (1.5 fmoles)

MAV1212-hEF1a-L7ae (1.5 fmoles)

6. (G_WT+ B + L)₂

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-2xKturn-eGFP (1.5 fmoles)

MAV1212-hEF1a-L7ae (1.5 fmoles)

//////

7. (G_M+ B)₁

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Multant CAG-2xKturn-eGFP (1.5 fmoles)

hEF1a-PirB (1.0 fmole = 0.99 uL)

8. (G_M+ B)2

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Multant CAG-2xKturn-eGFP (1.5 fmoles)

hEF1a-PirB (1.0 fmole = 0.99 uL)

9. (G_M+ B + L)₁

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Multant CAG-2xKturn-eGFP (1.5 fmoles)

MAV1212-hEF1a-L7ae (1.5 fmoles)

10. (G_M+ B + L)₂

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Multant CAG-2xKturn-eGFP (1.5 fmoles)

MAV1212-hEF1a-L7ae (1.5 fmoles)

//////

11. Neg Ctrl

hEF1a-PirB (3.2 fmoles = 2.05 uL)

With Lipofectamine

12. Neg Ctrl

hEF1a-PirB (3.2 fmoles = 2.05 uL)

With Lipofectamine

13. Neg/Neg Ctrl

No DNA

No Lipofectamine

14. Neg/Neg Ctrl

No DNA

No Lipofectamine

//////

RESULT: Transfection efficiency ___%. FACS data Data is available

Experiment #2L7ae Tuning

GOAL: Test the strength sensitivity of TAL14L7ae repression

14

complete

7/25/14

21

complete

Day One: Seed cells

15

complete

7/26/14

28

complete

Day Two: Transfect MAV1212-hEF1a-eBFP2, TAL14-mKate, hEF1a-GAL4VP16, hEF1a-TAL14, and hEF1a-PirB (dummy DNA) at ~500 ng/uL into HEK cells

16

complete

7/28/14 (4 pm): Flow Cytometry

Wild Type hEF1a-2xKturn-eGFP, MAV1212-hEF1a-L7ae, pEXPR: hEF1a-rtTA (169.0 ng/uL), GG-Donor (dummy DNA) all at ~500 ng/uL into HEK cells

29

complete

Day Three: DOX Induction

30

complete

Day Four (___ am): Flow Cytometry

DNA Dilution: MAV1212-hEF1a-eBFP2 (0.47 uL), TAL14-mKate Wild Type CAG-2xKturn-eGFP (0.62 96 uL), hEF1aMAV1212-TRE-GAL4VP16 L7ae (0.72 89 uL), pEXPR: hEF1a-TAL14 (___ rtTA (0.27 uL), Dummy DNA GG-Donor (to 1 ug)

24-WELL PLATE TRANSFECTION MAP:

(B)₁25 fmoles 076 (B)₂25 fmoles 076 3. Neg CtrlDummy DNA (.2 fmoles = 205 uL)With Lipofectamine

4. (B + R)₁

UASTAL14mKate 20 fmoles 61 5. (B + R)₂UASTAL14mKate 20 fmoles 61 //////6

7. (B + R + GAL)₁

Neg Ctrl

Dummy DNA (3.2 fmoles = 2.05 uL)

With Lipofectamine

UASTAL14mKate hEF1aGal4VP16 8. (B + R + GAL)₂UASTAL14mKate hEF1aGal4VP16

10. (B + R + GAL)₁

UASTAL14mKate hEF1aGal4VP16 (1.5 fmoles)

11. (B + R + GAL)₂

TAL14 UASTAL14mKate hEF1aGal4VP16 -TAL14

1.

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Dummy DNA (

1.

75 fmole =

1.

62 uL)

2.

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Dummy DNA (

1.

75 fmole =

1.

62 uL)

//////

3

.

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-

2xKturn-

eGFP (1.5 fmoles)

Dummy DNA (

0.

75 fmole = 0.

70 uL)

4.

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-

2xKturn-

eGFP (1.5 fmoles)

Dummy DNA (

0.

75 fmole = 0.

70 uL)

//////

5.

pEXPR: hEF1a-rtTA

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-

2xKturn-

eGFP (1.5 fmoles)

MAV1212-TRE-

L7ae (1.5 fmoles)

0 uM DOX

6.

pEXPR: hEF1a-rtTA

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-

2xKturn-

eGFP (1.5 fmoles)

MAV1212-

TRE-L7ae (1.5 fmoles)

//////

9. Neg/Neg Ctrl

No DNA

No Lipofectamine

1X DOX

7.

pEXPR: hEF1a-rtTA

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-

2xKturn-

eGFP (1.5 fmoles)

MAV1212-TRE-

L7ae (1.5 fmoles)

10X DOX

8.

pEXPR: hEF1a-

rtTA

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-

2xKturn-

eGFP (1.5 fmoles)

MAV1212-TRE-

L7ae (1.5 fmoles)

100X DOX

9.

pEXPR: hEF1a-rtTA

MAV1212-hEF1a

-eBFP2 (1.0 fmole)

Wild Type CAG-2xKturn-eGFP (1.5 fmoles)

//////

12. Neg/Neg Ctrl

No DNA

No Lipofectamine

Experiment #3

MAV1212-TRE-L7ae (1.5 fmoles)

1000X DOX

10.

pEXPR: hEF1a-rtTA

MAV1212-hEF1a-eBFP2 (1.0 fmole)

Wild Type CAG-2xKturn-eGFP (1.5 fmoles)

MAV1212-TRE-L7ae (1.5 fmoles)

2000X DOX

//////

11.

Dummy DNA (1 ug = ___ uL)

With Lipofectamine

12.

Dummy DNA (1 ug = ___ uL)

With Lipofectamine

13.

No DNA

No Lipofectamine

14.

No DNA

No Lipofectamine

//////

RESULT:Transfection efficiency ___%. Data can be found .

L7ae Quantification

GOAL: Use TASBE tools to quantify the repression of L7ae
32 complete 8/7/14: Seed cells 9 complete 8/8/14: Transfect hEF1a-rtTA (200.0 ng/uL), TRE-L7ae (200 ng/uL), Wild Type 2x-Kturn eGFP (200 ng/uL), TRE-mKate (200.0 ng/ uL), hEF1a-eBFP (200.0 ng/uL), hEF1a-mKate (200.0 ng/uL), hEF1a-eYFP (200.0 ng/uL), and GG Donor (200 ng/uL) into HEK cells 31 complete 8/10/14: (2 pm): Flow Cytometer

DNA Dilution: hEF1a-rtTA (0.60 uL), TRE-L7ae (1.48 uL), Wild Type 2x-Kturn eGFP (1.19 uL), TRE-mKate (1.0 uL), hEF1a-eBFP (0.93 uL), hEF1a-mKate (0.93 uL), hEF1a-eYFP (0.93 uL)

24-WELL PLATE TRANSFECTION MAP:
1. Neg Ctrl
Dummy DNA
With Lipofectamine

2. Neg Ctrl
Dummy DNA
With Lipofectamine

3. Neg
GOAL: Test the sensors in absence of siRNA
10 incomplete 7/26/14: Seed cells 11 incomplete 7/27/14: Transfect Low Sensor miR-144 (708.2 ng/uL), Low Sensor miR-181c (628.1 ng/uL), High Sensor miR-30d (1046.2 ng/uL), High Sensor miR-146a (828.8 ng/uL), High Sensor 125b (1159.5 ng/uL) and High Sensor let-7f (889.6 ng/uL) into HEK cells 12 incomplete 7/29/14: (4 pm): Flow Cytometer

DNA Dilution: Low Sensor miR-144 (___ uL),Low Sensor miR-181c (___ uL), High Sensor miR-30d (___ uL), High Sensor miR-146a (___ uL), High Sensor 125b (___ uL), High Sensor let-7f (___ uL)
24-WELL PLATE TRANSFECTION MAP:
Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
Neg
//////
1. miR-144
Low Sensor miR-144 ()
2. miR-181c
Low Sensor miR-181c (1.5 fmoles)
3. miR-30d
High Sensor miR-30d (1.5 fmoles)
4. miR-146a
High Sensor miR-146a (1.5 fmoles)
5. miR-125b
High Sensor miR-125b (1.5 fmoles)
6. let-7f
High Sensor let-7f (1.5 fmoles)
7. miR-144
Low Sensor miR-144 (1.5 fmoles)
8. miR-181c
Low Sensor miR-181c (1.5 fmoles)
9. miR-30d
High Sensor miR-30d (1.5 fmoles)
10. miR-146a
High Sensor miR-146a (1.5 fmoles)
11. miR-125b
High Sensor miR-125b (1.5 fmoles)
12. let-7f
High Sensor let-7f (1.5 fmoles)
//////
//////
////// ////// ////// //////
/Neg Ctrl
No DNA
No Lipofectamine
4. Neg/Neg Ctrl
No DNA
No Lipofectamine

//////
RESULT: Brief description of experimental outcome (mean transfection efficiency and implications). Link to results page with data analysis.
Experiment #4
GOAL: Test the sensors in the presence of siRNA
13 incomplete Day 1: Seed cells 9 incomplete Day 2: Transfect Low Sensor miR-144 (708.2 ng/uL), Low Sensor miR-181c (628.1 ng/uL), High Sensor miR-30d (1046.2 ng/uL), High Sensor miR-146a (828.8 ng/uL), High Sensor 125b (1159.5 ng/uL), High Sensor let-7f (889.6 ng/uL), Mature 144 (___ ng/uL), Mature 181c (___ ng/uL), Mature 30d (___ ng/uL), Mature 146a (___ ng/uL), Mature 125b (___ ng/uL) and Mature let-7f (___ ng/uL) into HEK cells 20 incomplete Day 4: (2 pm): Flow Cytometer

DNA Dilution: ___ uL Low Sensor miR-144, ___ uL Low Sensor miR-181c, ___ uL High Sensor miR-30d, ___ uL High Sensor miR-146a, ___ uL High Sensor 125b, ___ uL High Sensor let-7f , ___ uL Mature 144, ___ uL Mature 181c, ___ uL Mature 30d, ___ uL Mature 146a, ___ uL Mature 125b and ___ uL Mature let-7f
24-WELL PLATE TRANSFECTION MAP:

144

- Low Sensor miR-144
- Mature 144

- Low Sensor miR-181c
- Mature 181c

- High Sensor miR-30d
- Mature 30d

- High Sensor miR-146a
- Mature 146a

- High Sensor miR-125b
- Mature 125b

- High Sensor let-7f
- Mature let-7f

- Low Sensor miR-144
- Mature 144

- Low Sensor miR-181c
- Mature 181c

- High Sensor miR-30d
- Mature 30d

- High Sensor miR-146a
- Mature 146a

- High Sensor miR-125b
- Mature 125b

- High Sensor let-7f
- Mature let-7f

//////

5.

pEXPR: hEF1a-eYFP (1.0 fmoles)

Dummy DNA (1.5 fmoles = 4.4 uL)

6.

pEXPR: hEF1a-mKate (1.0 fmoles)

Dummy DNA (1.5 fmoles = 4.4 uL)

7.

pEXPR: hEF1a-eBFP (1.0 fmoles)

Dummy DNA (1.5 fmoles = 4.4 uL)

8.

pEXPR: hEF1a-eYFP (1.0 fmoles)

pEXPR: hEF1a-mKate (1.0 fmoles)

pEXPR: hEF1a-eBFP (1.0 fmoles)

Dummy DNA (0.75 fmoles = 2.2 uL)

9.

hEF1a-eBFP2 (0.5 fmole)

Wild Type CAG-2xKturn-eGFP (1.0 fmoles)

Dummy DNA (1.5 fmoles = 2.4 uL)

10.

pEXPR: hEF1a-rtTA (1.0 fmoles)

hEF1a-eBFP2 (0.5 fmole)

Wild Type CAG-2xKturn-eGFP (1.0 fmoles)

MAV1212-TRE-L7ae (1.0 fmoles)

pEXPR: TRE-mKate (1.0 fmoles)

0 uM DOX

11.

pEXPR: hEF1a-rtTA (1.0 fmoles)

hEF1a-eBFP2 (0.5 fmole)

Wild Type CAG-2xKturn-eGFP (1.0 fmoles)

MAV1212-TRE-L7ae (1.0 fmoles)

pEXPR: TRE-mKate (1.0 fmoles)

1X DOX

12.

pEXPR: hEF1a-rtTA 1.0 fmoles)

hEF1a-eBFP2 (0.5 fmole)

Wild Type CAG-2xKturn-eGFP (1.0 fmoles)

MAV1212-TRE-L7ae (1.0 fmoles)

pEXPR: TRE-mKate (1.0 fmoles)

10X DOX

13.

pEXPR: hEF1a-rtTA (1.0 fmoles)

hEF1a-eBFP2 (0.5 fmole)

Wild Type CAG-2xKturn-eGFP (1.0 fmoles)

MAV1212-TRE-L7ae (1.0 fmoles)

pEXPR: TRE-mKate (1.0 fmoles)

100X DOX

14.

pEXPR: hEF1a-rtTA (1.0 fmoles)

hEF1a-eBFP2 (0.5 fmole)

Wild Type CAG-2xKturn-eGFP (1.0 fmoles)

MAV1212-TRE-L7ae (1.0 fmoles)

pEXPR: TRE-mKate (1.0 fmoles)

1000X DOX

15.

pEXPR: hEF1a-rtTA (1.0 fmoles)

hEF1a-eBFP2 (0.5 fmole)

Wild Type CAG-2xKturn-eGFP (1.0 fmoles)

MAV1212-TRE-L7ae (1.0 fmoles)

pEXPR: TRE-mKate (1.0 fmoles)

2000X DOX

RESULT: Transfection efficiency ___%. Data can be found

L7ae Sensors (without siRNA)

GOAL: Test the sensors in absence of siRNA

10

complete

8.11.14: Seed cells

11

complete

8.12.14: Transfect 1 fmole of Low Sensor miR-144, Low Sensor miR-181c, High Sensor miR-30d, High Sensor miR-146a, High Sensor 125b, and High Sensor let-7f and 0.5 fmoles of pEXPR: hEF1a-mKate all at 200 ng/uL into HEK cells in addition to Dummy DNA (GG Donor) to fill the wells to 1 ug

12

complete

8.14.14: (4 pm): Flow Cytometer

DNA Dilution: hEF1a-mKate (0.46 uL), Wild Type Kturn-eGFP (1.19 uL), Low Sensor miR-144 (1.29 uL),Low Sensor miR-181c (1.29 uL), High Sensor miR-30d (1.37 uL), High Sensor miR-146a (1.37 uL), High Sensor 125b (1.37 uL), High Sensor let-7f (1.37 uL)

24-WELL PLATE TRANSFECTION MAP:

1. miR-144

pEXPR: hEF1a-mKate

Low Sensor miR-144

Dummy DNA (2.9 uL = 1 fmoles)

2. miR-181c

pEXPR: hEF1a-mKate

Low Sensor miR-181c

Dummy DNA (2.9 uL = 1 fmoles)

3. miR-30d

pEXPR: hEF1a-mKate

Wild Type CAG-2xKturn-eGFP

High Sensor miR-30d

Dummy DNA (2.2 uL = 0.75 fmoles)

4. miR-146a

pEXPR: hEF1a-mKate

Wild Type CAG-2xKturn-eGFP

High Sensor miR-146a

Dummy DNA (2.2 uL = 0.75 fmoles)

5. miR-125b

pEXPR: hEF1a-mKate

Wild Type CAG-2xKturn-eGFP

High Sensor miR-125b

Dummy DNA (2.2 uL = 0.75 fmoles)

6. let-7f

pEXPR: hEF1a-mKate

Wild Type CAG-2xKturn-eGFP

High Sensor let-7f

Dummy DNA (2.2 uL = 0.75 fmoles)

1. miR-144

pEXPR: hEF1a-mKate

Low Sensor miR-144

Dummy DNA (2.9 uL = 1 fmoles)

2. miR-181c

pEXPR: hEF1a-mKate

Low Sensor miR-181c

Dummy DNA (2.9 uL = 1 fmoles)

3. miR-30d

pEXPR: hEF1a-mKate

Wild Type CAG-2xKturn-eGFP

High Sensor miR-30d

Dummy DNA (2.2 uL = 0.75 fmoles)

4. miR-146a

pEXPR: hEF1a-mKate

Wild Type CAG-2xKturn-eGFP

High Sensor miR-146a

Dummy DNA (2.2 uL = 0.75 fmoles)

5. miR-125b

pEXPR: hEF1a-mKate

Wild Type CAG-2xKturn-eGFP

High Sensor miR-125b

Dummy DNA (2.2 uL = 0.75 fmoles)

6. let-7f

pEXPR: hEF1a-mKate

Wild Type CAG-2xKturn-eGFP

High Sensor let-7f (

Dummy DNA (2.2 uL = 0.75 fmoles)

//////

13.

pEXPR: hEF1a-mKate

Dummy DNA (5.1uL = 1.75 fmoles)

13.

pEXPR: hEF1a-mKate

Wild Type CAG-2xKturn-eGFP (1.5 fmoles)

Dummy DNA (3.6 uL = 1.25 fmoles)

19.

Dummy DNA

With Lipofectamine

20.

Dummy DNA

With Lipofectamine

21.

No DNA

No Lipofectamine

22.

No DNA

No Lipofectamine

RESULT: Transfection efficiency ___%. Data can be found .

L7ae Sensors (with siRNA)

GOAL: Test the sensors in the presence of siRNA
-1 incomplete 33 complete 8.12.14: Seed cells 34 complete 8.13.14: Transfect 1 fmole of Low Sensor miR-144, Low Sensor miR-181c, High Sensor miR-30d, High Sensor miR-146a, High Sensor 125b, and High Sensor let-7f and 0.5 fmoles of pEXPR: hEF1a-mKate all at 200 ng/uL into HEK cells in addition to Dummy DNA (GG Donor) to fill the wells to 1 ug. 35 complete 8.15.14: (4 pm): Flow Cytometer
DNA Dilution: hEF1a-mKate (0.46 uL), Wild Type Kturn-eGFP (1.19 uL), Low Sensor miR-144 (1.29 uL),Low Sensor miR-181c (1.29 uL), High Sensor miR-30d (1.37 uL), High Sensor miR-146a (1.37 uL), High Sensor 125b (1.37 uL), High Sensor let-7f (1.37 uL), 5 uL Mature 144, 5 uL Mature 181c, 5 uL Mature 30d, 5 uL Mature 146a, 5 uL Mature 125b and 5 uL Mature let-7f

24-WELL PLATE TRANSFECTION MAP:
1. miR-144
pEXPR: hEF1a-mKate
Low Sensor miR-144
siRNA-144
Dummy DNA (2.9 uL = 1 fmoles)
2. miR-181c
pEXPR: hEF1a-mKate
Low Sensor miR-181c
siRNA-181c
Dummy DNA (2.9 uL = 1 fmoles)
3. miR-30d
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-30d
siRNA-30d
Dummy DNA (2.2 uL = 0.75 fmoles)
4. miR-146a
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-146a
siRNA-146a
Dummy DNA (2.2 uL = 0.75 fmoles)
5. miR-125b
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-125b
siRNA-125b
Dummy DNA (2.2 uL = 0.75 fmoles)
6. let-7f
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor let-7f
siRNA-7f
Dummy DNA (2.2 uL = 0.75 fmoles)
1. miR-144
pEXPR: hEF1a-mKate
Low Sensor miR-144
siRNA-144
Dummy DNA (2.9 uL = 1 fmoles)
2. miR-181c
pEXPR: hEF1a-mKate
Low Sensor miR-181c
siRNA-181c
Dummy DNA (2.9 uL = 1 fmoles)
3. miR-30d
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-30d
siRNA-30d
Dummy DNA (2.2 uL = 0.75 fmoles)
4. miR-146a
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-146a
siRNA-46a
Dummy DNA (2.2 uL = 0.75 fmoles)
5. miR-125b
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-125b
siRNA-125b
Dummy DNA (2.2 uL = 0.75 fmoles)
6. let-7f
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor let-7f
siRNA-7f
Dummy DNA (2.2 uL = 0.75 fmoles)
//////
//////
////// ////// ////// //////
13.
pEXPR: hEF1a-mKate
Dummy DNA (5.1uL = 1.75 fmoles)
13.
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
Dummy DNA (3.6 uL = 1.25 fmoles)
19.
Dummy DNA
With Lipofectamine
20.
Dummy DNA
With Lipofectamine
21.
No DNA
No Lipofectamine
22.
No DNA
No Lipofectamine

RESULT: Transfection efficiency ___%. Data can be found .
L7ae Sensors (with and without siRNA)
GOAL: Test the sensors in the presence and absence of siRNA
-1 incomplete 14 incomplete Day 1: Seed cells 15 incomplete Day 2: Transfect 1 fmole of Low Sensor miR-144, Low Sensor miR-181c, High Sensor miR-30d, High Sensor miR-146a, High Sensor 125b, and High Sensor let-7f and 0.5 fmoles of pEXPR: hEF1a-mKate all at 200 ng/uL into HEK cells in addition to Dummy DNA (GG Donor) to fill the wells to 1 ug. 16 incomplete Day 4: (___ pm): Flow Cytometer
DNA Dilution: hEF1a-mKate (0.46 uL), Wild Type Kturn-eGFP (1.60 uL), Low Sensor miR-144 (1.29 uL),Low Sensor miR-181c (1.39 uL), High Sensor miR-30d (1.01 uL), High Sensor miR-146a (1.16 uL), High Sensor 125b (1.47 uL), High Sensor let-7f (1.37 uL), 5 uL Mature 144, 5 uL Mature 181c, 5 uL Mature 30d, 5 uL Mature 146a, 5 uL Mature 125b and 5 uL Mature let-7f

24-WELL PLATE TRANSFECTION MAP:
1. miR-144
pEXPR: hEF1a-mKate
Low Sensor miR-144
Dummy DNA (2.9 uL = 1 fmoles)
2. miR-181c
pEXPR: hEF1a-mKate
Low Sensor miR-181c
Dummy DNA (2.9 uL = 1 fmoles)
3. miR-30d
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-30d
Dummy DNA (2.2 uL = 0.75 fmoles)
4. miR-146a
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-146a
Dummy DNA (2.2 uL = 0.75 fmoles)
5. miR-125b
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-125b
Dummy DNA (2.2 uL = 0.75 fmoles)
6. let-7f
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor let-7f
Dummy DNA (2.2 uL = 0.75 fmoles)
1. miR-144
pEXPR: hEF1a-mKate
Low Sensor miR-144
siRNA-144
Dummy DNA (2.9 uL = 1 fmoles)
2. miR-181c
pEXPR: hEF1a-mKate
Low Sensor miR-181c
siRNA-181c
Dummy DNA (2.9 uL = 1 fmoles)
3. miR-30d
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-30d
siRNA-30d
Dummy DNA (2.2 uL = 0.75 fmoles)
4. miR-146a
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-146a
siRNA-146a
Dummy DNA (2.2 uL = 0.75 fmoles)
5. miR-125b
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor miR-125b
siRNA-125b
Dummy DNA (2.2 uL = 0.75 fmoles)
6. let-7f
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP
High Sensor let-7f
siRNA-7f
Dummy DNA (2.2 uL = 0.75 fmoles)
//////
//////
////// ////// ////// //////
13.
pEXPR: hEF1a-mKate
Dummy DNA (5.1uL = 1.75 fmoles)
13.
pEXPR: hEF1a-mKate
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
Dummy DNA (3.6 uL = 1.25 fmoles)
19.
Dummy DNA
With Lipofectamine
20.
Dummy DNA
With Lipofectamine
21.
No DNA
No Lipofectamine
22.
No DNA
No Lipofectamine

RESULT: Transfection efficiency ___%. Data can be found .

L7ae Sensors (Multi Input)
GOAL: Test the sensors in the presence and absence of siRNA
-1 incomplete 20 complete 9.23.14: Seed cells 42 complete 9.24.14: Transfect 1 fmole of Low Sensor miR-144, High Sensor miR-30d, 0.5 fmoles pEXPR: hEF1a-mKate all at 200 ng/uL into HEK cells in addition to Dummy DNA (GG Donor) to fill the wells to 1 ug. 43 complete 9.26.14: (___ pm): Flow Cytometry
DNA Dilution: hEF1a-mKate (0.46 uL), Wild Type Kturn-eGFP (1.19 uL), Low Sensor miR-144 (1.29 uL),High Sensor miR-30d, 5 uL Mature 144, 5 uL Mature 30d

24-WELL PLATE TRANSFECTION MAP:

1.
Untransfected

2.
pEXPR: hEF1a-mKate
Low Sensor miR-144c
Dummy DNA (2.9 uL = 1 fmoles)

//////

//////

//////

//////
3.
pEXPR: hEF1a-mKate
Low Sensor miR-144
Dummy DNA (2.9 uL = 1 fmoles)
4.
pEXPR: hEF1a-mKate
High Sensor miR-30d
Dummy DNA (2.9 uL = 1 fmoles)5
5.
pEXPR: hEF1a-mKate
Low Sensor miR-144
High Sensor miR-30d
Wild Type CAG-2xKturn-eGFP
6.
pEXPR: hEF1a-mKate
Low Sensor miR-144
High Sensor miR-30d
Wild Type CAG-2xKturn-eGFP
siRNA-30d
7.
pEXPR: hEF1a-mKate
Low Sensor miR-144
High Sensor miR-30d
Wild Type CAG-2xKturn-eGFP
siRNA-144
8.
pEXPR: hEF1a-mKate
Low Sensor miR-144
High Sensor miR-30d
Wild Type CAG-2xKturn-eGFP
siRNA-30d
siRNA-144
//////
9.
pEXPR: hEF1a-mKate
High Sensor miR-125b
Dummy DNA (2.9 uL = 1 fmoles)5
10.
pEXPR: hEF1a-mKate
Low Sensor miR-125b
High Sensor miR-30d
Wild Type CAG-2xKturn-eGFP
11.
pEXPR: hEF1a-mKate
Low Sensor miR-125b
High Sensor miR-30d
Wild Type CAG-2xKturn-eGFP
siRNA-30d
12.
pEXPR: hEF1a-mKate
Low Sensor miR-125b
High Sensor miR-30d
Wild Type CAG-2xKturn-eGFP
siRNA-125b
13.
pEXPR: hEF1a-mKate
Low Sensor miR-125b
High Sensor miR-30d
Wild Type CAG-2xKturn-eGFP
siRNA-30d
siRNA-125b
//////
14.
pEXPR: hEF1a-mKate
High Sensor miR-181c
Dummy DNA (2.9 uL = 1 fmoles)5
15.
pEXPR: hEF1a-mKate
Low Sensor miR-144
High Sensor miR-181c
Wild Type CAG-2xKturn-eGFP
16.
pEXPR: hEF1a-mKate
Low Sensor miR-144
High Sensor miR-181c
Wild Type CAG-2xKturn-eGFP
siRNA-181c
17.
pEXPR: hEF1a-mKate
Low Sensor miR-144
High Sensor miR-181c
Wild Type CAG-2xKturn-eGFP
siRNA-144
18.
pEXPR: hEF1a-mKate
Low Sensor miR-144
High Sensor miR-181c
Wild Type CAG-2xKturn-eGFP
siRNA-181c
siRNA-144

RESULT: Transfection efficiency ___%. Data can be found .
TAL14 Repression
GOAL: Test the strength of TAL14
44 complete 7/25/14: Seed cells 45 complete 7/26/14: Transfect MAV1212-hEF1a-eBFP2, TAL14-mKate, hEF1a-GAL4VP16, hEF1a-TAL14, and hEF1a-PirB (dummy DNA) at ~500 ng/uL into HEK cells 46 complete 7/28/14 (4 pm): Flow Cytometry

DNA Dilution: MAV1212-hEF1a-eBFP2 (0.47 uL), TAL14-mKate (0.62 uL), hEF1a-GAL4VP16 (0.72 uL), hEF1a-TAL14 (___ uL), Dummy DNA (to 1 ug)

24-WELL PLATE TRANSFECTION MAP:
1. (B)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Dummy DNA (2.5 fmoles = 0.76 uL)
2. (B)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Dummy DNA (2.5 fmoles = 0.76 uL)
////// //////
//////

3. Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
4. (B + R)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
Dummy DNA (2.0 fmoles = 0.61 uL)
5. (B + R)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
Dummy DNA (2.0 fmoles = 0.61 uL)
//////
////// //////
6. Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
7. (B + R + GAL)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
8. (B + R + GAL)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
//////
//////

//////
9. Neg/Neg Ctrl
No DNA
No Lipofectamine
10. (B + R + GAL)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
hEF1a-TAL14 (1.5 fmoles)
11. (B + R + GAL)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
hEF1a-TAL14 (1.5 fmoles)
//////
////// ////// 12. Neg/Neg Ctrl
No DNA
No Lipofectamine

Results: Transfection efficiency ___%. Data can be found
TAL14 Tuning
GOAL: Determine how much TAL14 is needed to repress TAL14-UAS-mKate
26 complete Day One: Seed cells 27 complete Day Two: Transfect MAV1212-hEF1a-eBFP2, TAL14-mKate, hEF1a-GAL4VP16, hEF1a-TAL14, and hEF1a-PirB (dummy DNA) at ~500 ng/uL into HEK cells 25 complete Day Four (12:30 pm): Flow Cytometry

DNA Dilution: MAV1212-hEF1a-eBFP2 (0.47 uL), TAL14-mKate (0.62 uL), hEF1a-GAL4VP16 (0.72 uL), hEF1a-TAL14 (0.22 uL = 1 fmol), Dummy DNA (to 1 ug)

24-WELL PLATE TRANSFECTION MAP:
1.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Dummy DNA (1.75 fmoles = 4.06 uL)
2.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Dummy DNA (1.75 fmoles = 04.06 uL)
3.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
Dummy DNA (1.0 fmoles = 2.32 uL)
4.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
Dummy DNA (1.0 fmoles = 2.32 uL)
5.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
Dummy DNA (0.75 fmoles = 1.74 uL)
6.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
Dummy DNA (0.75 fmoles = 1.74 uL)
7.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (1.0 fmoles)
8.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (1.5 fmoles)
9.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (2.0 fmoles)
10.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (2.5 fmoles)
11.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (3.0 fmoles)
12.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (3.5 fmoles)
13.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (4.0 fmoles)
14.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (4.5 fmoles)
15.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (5.0 fmoles)
16.
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.0 fmoles)
hEF1a-TAL14 (10.0 fmoles)
17.
Neg Ctrl
Dummy DNA
With Lipofectamine
Neg Ctrl
Dummy DNA
With Lipofectamine
Neg/Neg Ctrl
No DNA
No Lipofectamine
Neg/Neg Ctrl
No DNA
No Lipofectamine

//////

//////
RESULT: Brief description of experimental outcome (mean transfection efficiency and implications). Link to results page with data analysis.
Experiment #5
GOAL: Test the sensitivity of L7ae repression
21 incomplete Day One: Seed cells 28 incomplete Day Two: Transfect MAV1212-hEF1a-eBFP2, Mutant hEF1a-2xKturn-eGFP, Wild Type hEF1a-2xKturn-eGFP, MAV1212-hEF1a-L7ae, hEF1a-PirB (dummy DNA) all at ~500 ng/uL into HEK cells 29 incomplete Day Three: DOX Induction 30 incomplete Day Four (___ am): Flow Cytometry
DNA Dilution: MAV1212-hEF1a-eBFP2 (0.47 uL), Wild Type CAG-2xKturn-eGFP (0.96 uL), Mutant CAG-2xKturn-eGFP (0.96 uL), MAV1212-hEF1a-L7ae (0.71 uL), hEF1a-PirB (to 1 ug)
24-WELL PLATE TRANSFECTION MAP:
19. Neg Ctrl
Dummy DNA (1 ug)
With Lipofectamine
20. Neg Ctrl
Dummy DNA (1 ug)
With Lipofectamine
1. (B)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
hEF1aUAS-TAL14-PirB mKate (1.5 fmole = fmoles)
hEF1a-Gal4VP16 (1.60 uL0 fmoles)
hEF1a-TAL14 (15.0 fmoles)
18. 2. (B)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
hEF1aUAS-TAL14-PirB mKate (1.5 fmole = 1.60 uL)
3. (G_WT+ B)₁
fmoles)
hEF1a-Gal4VP16 MAV1212-hEF1a-eBFP2 (1.0 fmolefmoles)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
hEF1a-PirB (1.0 fmole = 0.99 uL)
4. (G_WT+ B)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
hEF1a-PirB (1.0 fmole = 0.99 uL)
5. (G_M+ B)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Multant CAG-2xKturn-eGFP (1.5 fmoles)
hEF1a-PirB (1.0 fmole = 0.99 uL)
6. (G_M+ B)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Multant CAG-2xKturn-eGFP (1.5 fmoles)
hEF1a-PirB (1.0 fmole = 0.99 uL)
7. (G_WT+ B + L)₁
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-TRE-L7ae (1.5 fmoles)
0 uM DOX
8. (G_WT+ B + L)₂
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-TRE-L7ae (1.5 fmoles)
1X DOX
9. (G_WT+ B + L)₃
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-TRE-L7ae (1.5 fmoles)
10X DOX
10. (G_WT+ B + L)₄
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-TRE-L7ae (1.5 fmoles)
100X DOX
11. (G_WT+ B + L)₅
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-TRE-L7ae (1.5 fmoles)
1000X DOX
12. (G_WT+ B + L)₆
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Wild Type CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-TRE-L7ae (1.5 fmoles)
2000X DOX
13. (G_M+ B + L)₁
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Mutant CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
0 uM DOX
14. (G_M+ B + L)₂
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Mutant CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
1X DOX
15. (G_M+ B + L)₃
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Mutant CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
10X DOX
16. (G_M+ B + L)₄
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Mutant CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
100X DOX
17. (G_M+ B + L)₅
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Mutant CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
1000X DOX
18. (G_M+ B + L)₆
pEXPR: hEF1a-rtTA
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Mutant CAG-2xKturn-eGFP (1.5 fmoles)
MAV1212-hEF1a-L7ae (1.5 fmoles)
2000X DOX
21. Neg/Neg Ctrl
No DNA
No Lipofectamine
22. Neg/Neg Ctrl
No DNA
No Lipofectamine

RESULT: Brief description of experimental outcome (mean transfection efficiency and implications). Link to results page with data analysis.
Experiment #6
GOAL: Test the strength of TAL14
34 complete 7/25/14: Seed cells 35 complete 7/26/14: Transfect MAV1212-hEF1a-eBFP2, TAL14-mKate, hEF1a-GAL4VP16, hEF1a-TAL14, and hEF1a-PirB (dummy DNA) at ~500 ng/uL into HEK cells 25 complete 7/28/14 (4 pm): Flow Cytometry

DNA Dilution: MAV1212-hEF1a-eBFP2 (0.47 uL), TAL14-mKate (0.62 uL), hEF1a-GAL4VP16 (0.72 uL), hEF1a-TAL14 (___ uL), Dummy DNA (to 1 ug)
24-WELL PLATE TRANSFECTION MAP:
1. (B)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Dummy DNA (2.5 fmoles = 0.76 uL)
2. (B)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
Dummy DNA (2.5 fmoles = 0.76 uL)
3. (B + R)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
Dummy DNA (2.0 fmoles = 0.61 uL)
4. (B + R)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
Dummy DNA (2.0 fmoles = 0.61 uL)
5. (B + R + GAL)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
6. (B + R + GAL)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)

10. (B + R + GAL)₁
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
hEF1a-TAL14 (1.5 fmoles)
11. (B + R + GAL)₂
MAV1212-hEF1a-eBFP2 (1.0 fmole)
UAS-TAL14-mKate (1.5 fmoles)
hEF1a-Gal4VP16 (1.5 fmoles)
hEF1a-TAL14 (1.5 fmoles)

3. Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
6. Neg Ctrl
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
9. Neg/Neg Ctrl
No DNA
No Lipofectamine
12. Neg/Neg Ctrl
No DNA
No Lipofectamine

RESULT: Brief description of experimental outcome (mean transfection efficiency and implications). Link to results page with data analysis.
Toggle Cloak
Treatment
hEF1a-TAL14 (20.0 fmoles)
19.
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
20.
Dummy DNA (3.2 fmoles = 2.05 uL)
With Lipofectamine
21.
No DNA
No Lipofectamine
22.
No DNA
No Lipofectamine

RESULT: Transfection efficiency ___%. Data can be found here.
Toggle Cloak
Treatment
Hef1a: eBFP 250ng
TRE: miRNA1
Cloak
Testing effectiveness of miRNA1–miRNA4 in down-regulating BACE1 expression v1
A1
Hef1a: eBFP 250ng
Dummy DNA 750ng

Positive Control
A2
Hef1a: eBFP 250ng
Hef1a: BACE1 250ng
Dummy DNA 500ng
Negative Control
A3
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

0 nM Dox
A4
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
0 nM Dox
A5
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE 250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

1000 nM Dox
A6
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
1000 nM Dox
A7
Hef1a:mKATE 250ng
Hef1a:BFP 250ng
Dummy DNA 500ng

Testing inducible expression of BACE2
B1
Hef1a:eBFP 333ng
Dummy DNA 666ng
Negative Control
B2
Hef1a:eBFP 333ng
Hef1a:rtTA 333ng
TRE:BACE2 333ng
0 nM Dox
B3
Hef1a:eBFP 333ng
Hef1a:rtTA 333ng
TRE:BACE2 333ng
1000 nM Dox
B4
No DNA (untransfected)

Double negative control

Transfection: Week of 8/11
A1
Hef1a: eBFP 250ng
Dummy DNA 750ng

Negative BACE1 Control
A2
Hef1a: eBFP 250ng
Hef1a: BACE1 250ng
Dummy DNA 500ng

Positive BACE1 Control
A3
Hef1a:mKATE 250ng
Hef1a:BFP 250ng
Dummy DNA 500ng

mKATE control
A4
Hef1:miRNAg1 250ng
Hef1a:BFP 250ng
Dummy DNA 500ng

miRNA1g control
A5
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

0 nM Dox
A6
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
0 nM Dox
A7
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE 250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

1000 nM Dox
A8
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
1000 nM Dox
A9
Hef1a: eBFP 250ng
TRE: miRNA2-mKATE250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

0 nM Dox
A10
Hef1a: eBFP 250ng
TRE: miRNA2-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
0 nM Dox
A11
Hef1a: eBFP 250ng
TRE: miRNA2-mKATE 250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

1000 nM Dox
A12
Hef1a: eBFP 250ng
TRE: miRNA2-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
1000 nM Dox
A13
Hef1a: eBFP 250ng
TRE: miRNA3-mKATE250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

0 nM Dox
A14
Hef1a: eBFP 250ng
TRE: miRNA3-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
0 nM Dox
A15
Hef1a: eBFP 250ng
TRE: miRNA3-mKATE 250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

1000 nM Dox
A16
Hef1a: eBFP 250ng
TRE: miRNA3-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
1000 nM Dox
A17
Hef1a: eBFP 250ng
TRE: miRNA4-mKATE250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

0 nM Dox
A18
Hef1a: eBFP 250ng
TRE: miRNA4-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
0 nM Dox
A19
Hef1a: eBFP 250ng
TRE: miRNA4-mKATE 250ng
Hef1a: rtTA 250ng
Dummy DNA 250ng

1000 nM Dox
A20
Hef1a: eBFP 250ng
TRE: miRNA4-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
1000 nM Dox
B1
Hef1a:eBFP 333ng
Dummy DNA 666ng

Negative Control
B2
Hef1a:eBFP 333ng
Hef1a:rtTA 333ng
TRE:BACE2 333ng

0 nM Dox
B3
Hef1a:eBFP 333ng
Hef1a:rtTA 333ng
TRE:BACE2 333ng

1000 nM Dox
B4
No DNA (untransfected)

Double negative control
Transfection 9/17

Cloak
Testing effectiveness of miRNA1–miRNA4 in down-regulating BACE1 expression
Repeat for miRNA2, miRNA3, and miRNA4 (same arrangement of wells as shown here, just substituting out "miRNA1" for the appropriate miRNA)
Hef1a: eBFP 1000ng
Negative Control
Hef1a: eBFP 500ng
Hef1a: BACE1 500ng
Positive Control

Hef1a: eBFP 333ng
TRE: miRNA1 333ng
Hef1a: rtTA 333ng
0 nM Dox
A1
Hef1a: eBFP 250ng
Dummy DNA 750ng

Negative BACE1 Control
A2
Hef1a: eBFP 250ng
Hef1a: BACE1 250ng
Dummy DNA 500ng

Positive BACE1 Control
A3
Hef1a:mKATE 250ng
Hef1a:BFP 250ng
Dummy DNA 500ng

mKATE control
A4
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE
250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
0 nM Dox
Hef1a: eBFP 333ng
TRE: miRNA1 333ng
Hef1a: rtTA 333ng
1 nM Dox

A5
Hef1a: eBFP 250ng
TRE: miRNA1-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
1
1000 nM Dox
A6
Hef1a: eBFP
333ng
250ng
TRE:
miRNA1 333ng
miRNA2-mKATE 250ng
Hef1a: rtTA
333ng10
250ng
Hef1a: BACE1 250ng
0 nM Dox
A7
Hef1a: eBFP 250ng
TRE:
miRNA1
miRNA2-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
10
1000 nM Dox
A8
Hef1a: eBFP
333ng
250ng
TRE:
miRNA1 333ng
miRNA3-mKATE 250ng
Hef1a: rtTA
333ng100
250ng
Hef1a: BACE1 250ng
0 nM Dox
A9
Hef1a: eBFP 250ng
TRE:
miRNA1
miRNA3-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
100
1000 nM Dox
A10
Hef1a: eBFP
333ng
250ng
TRE:
miRNA1 333ng
miRNA4-mKATE 250ng
Hef1a: rtTA
333ng1000
250ng
Hef1a: BACE1 250ng
0 nM Dox
A11
Hef1a: eBFP 250ng
TRE:
miRNA1 TRE: miRNA1
miRNA4-mKATE 250ng
Hef1a: rtTA 250ng
Hef1a: BACE1 250ng
1000 nM Dox
B1
Hef1a:eBFP 333ng
Dummy DNA 666ng

Negative Control
B2
Hef1a:eBFP
333ng
Hef1a:rtTA 333ng
TRE:BACE2 333ng

2000 TRE: miRNA1 250ng
0 nM Dox
B3
Hef1a:eBFP
250ng
333ng
Hef1a:rtTA
250ng
333ng
Hef1a: BACE1 250ng
2000 nM Dox
TRE:BACE2 333ng

1000 nM Dox
B4
No DNA (untransfected)

Double negative control

Child pages

Versions Compared

Old Version 99

New Version Current

Key

1. (B)₁ MAV1212-hEF1a-eBFP2 (1.0 fmole) Dummy DNA (2.5 fmoles = 0.76 uL)	2. (B)₂ MAV1212-hEF1a-eBFP2 (1.0 fmole) Dummy DNA (2.5 fmoles = 0.76 uL)	3. (B + R)₁ MAV1212-hEF1a-eBFP2 (1.0 fmole) UAS-TAL14-mKate (1.5 fmoles) Dummy DNA (2.0 fmoles = 0.61 uL)	4. (B + R)₂ MAV1212-hEF1a-eBFP2 (1.0 fmole) UAS-TAL14-mKate (1.5 fmoles) Dummy DNA (2.0 fmoles = 0.61 uL)	5. (B + R + GAL)₁ MAV1212-hEF1a-eBFP2 (1.0 fmole) UAS-TAL14-mKate (1.5 fmoles) hEF1a-Gal4VP16 (1.5 fmoles)	6. (B + R + GAL)₂ MAV1212-hEF1a-eBFP2 (1.0 fmole) UAS-TAL14-mKate (1.5 fmoles) hEF1a-Gal4VP16 (1.5 fmoles)

10. (B + R + GAL)₁ MAV1212-hEF1a-eBFP2 (1.0 fmole) UAS-TAL14-mKate (1.5 fmoles) hEF1a-Gal4VP16 (1.5 fmoles) hEF1a-TAL14 (1.5 fmoles)	11. (B + R + GAL)₂ MAV1212-hEF1a-eBFP2 (1.0 fmole) UAS-TAL14-mKate (1.5 fmoles) hEF1a-Gal4VP16 (1.5 fmoles) hEF1a-TAL14 (1.5 fmoles)
3. Neg Ctrl Dummy DNA (3.2 fmoles = 2.05 uL) With Lipofectamine	6. Neg Ctrl Dummy DNA (3.2 fmoles = 2.05 uL) With Lipofectamine	9. Neg/Neg Ctrl No DNA No Lipofectamine	12. Neg/Neg Ctrl No DNA No Lipofectamine